The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Subcutaneous apomorphine in the treatment of Parkinson's disease.
Open accessAbstract
Apomorphine a dopamine receptor agonist was given subcutaneously to 57 levodopa treated parkinsonian patients with refractory off-period disabilities for a median period of 16 months. In 30 given intermittent suprathreshold injections the mean number of hours spent in a disabling off state fell from 6.9 to 2.9. Similar benefit was observed in 21 patients receiving continuous infusions with additional boluses on demand by mini-pump (mean reduction of hours off from 9.9 to 4.5). Twelve patients have been treated for over two years without tachyphylaxis or loss of response. The incidence of neuropsychiatric side-effects has been low (7%). Six patients failed to show a sustained worthwhile response; severe disabilities during "on" periods being the major problem. Subcutaneous apomorphine is proposed as an effective treatment for patients with incapacitating "off" period disabilities refractory to oral medication and should be considered before experimental implantation procedures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BUNNEY, B. S., AGHAJANIAN, G. K., & ROTH, R. H. (1973) · Nature New Biology · doi:10.1038/newbio245123a0 · Cited by 434
SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONS
Stibe, C. M. H., Kempster, P. A., Lees, A. J., & Stern, G. M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91193-2 · Cited by 323
Self-citationIMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE
Birkmayer, W., Riederer, P., Ambrozi, L., & Youdim, M. B. H. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91940-7 · Cited by 297
DEPRENYL IN PARKINSON'S DISEASE
Lees, A. J., Kohout, L. J., Shaw, K. M., Stern, G. M., Elsworth, J. D., Sandler, M., & Youdim, M. B. H. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90725-5 · Cited by 292
Self-citationON-OFF FLUCTUATIONS IN PARKINSON'S DISEASE: A CLINICAL AND NEUROPHARMACOLOGICAL STUDY
HARDIE, R. J., LEES, A. J., & STERN, G. M. (1984) · Brain · doi:10.1093/brain/107.2.487 · Cited by 277
Self-citationMathers, S. E., Kempster, P. A., Swash, M., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.12.1503 · Cited by 159
Self-citationAnal Sphincter Dysfunction in Parkinson's Disease
Mathers, S. E., Kempster, P. A., Law, P. J., Frankel, J. P., Bartram, C. I., Lees, A. J., Stern, G. M., & Swash, M. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460037010 · Cited by 158
Self-citationCortical auditory disorders: clinical and psychoacoustic features.
Mendez, M. F., & Geehan, G. R. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.1.1 · Cited by 150
ROLE OF SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN VOIDING DYSFUNCTION
CHRISTMAS, T. J., Chapple, C. R., Lees, A. J., Kempster, P. A., Frankel, J. P., Stern, G. M., & Milroy, E. J. G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90932-4 · Cited by 146
Self-citationCorsini, G. U., Zompo, M. D., Gessa, G. L., & Mangoni, A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91725-2 · Cited by 143
Handbook of Parkinson's Disease
Zakov, Z. N., & HANSON, M. (1988) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.55.5.483 · Cited by 136
Injected Apomorphine and Orally Administered Levodopa in Parkinsonism
Düby, S., Cotzias, G. C., Papavasiliou, P. S., et al. (1972) · Archives of Neurology · doi:10.1001/archneur.1972.00490180010004 · Cited by 134
Agid, Y., Bonnet, A. M., Pollak, P., Signoret, J. L., & Lhermitte, F. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91003-1 · Cited by 103
Subcutaneous apomorphine in Parkinson's disease.
Pollak, P., Champay, A. S., Hommel, M., et al. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.4.544 · Cited by 69
Clinical and biochemical studies with controlled‐release levodopa/carbidopa
Nutt, J. G., Woodward, W. R., & Carter, J. H. (1986) · Neurology · doi:10.1212/wnl.36.9.1206 · Cited by 60
Kempster, P. A., Lees, A. J., Crichton, P. R., et al. (1989) · Movement Disorders · doi:10.1002/mds.870040108 · Cited by 40
Self-citationThe use of dopamine agonists in the treatment of schizophrenia.
Gu, C., Gf, P., Bernardi, F., Bocchetta, A., & Del Zompo, M. (1981) · PubMed · Cited by 36
Barker, R. A., Duncan, J. S., & Lees, A. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92183-1 · Cited by 34
Self-citation
Cited by
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Self-citationThe scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
Metadata
- Authors
- Frankel, J. P., Lees, A. J., Kempster, P. A., & Stern, G. M.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1990-02-01
- Volume
- 53
- Issue
- 2
- Pages
- 96-101
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2132528735
- Cited by
- 306
- References
- 18
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.